Whilst confirmation of the global manufacturing deal was a tick in the de-risking of cgp it also signaled that the launch/sales side of thing wouldn't happen until Q4CY so no surprise about the pull back in the interim.
The Quarterly may have made a few nervous as well, but it did make note of the R&D Tax rebate of $515k and that it was received after June.
Hopefully the next newsletter isn't too far away and might put a few minds at ease.
I've spoken with management this week and remain comfortable with the business objectives and positioning.
Has anybody else seen the Breathe Right ads that have hit the airwaves at night in the past few weeks? Wonder if they need to beef up their branding now that patents are close to expiry?
CGP Price at posting:
4.2¢ Sentiment: Hold Disclosure: Held